As part of the rise of digital health, healthcare providers want to better integrate data from devices and remote patient monitoring platforms into patient health records.
TytoCare, maker of a home medical exam and telehealth device kit, is stepping up its partnership with electronic medical records giant Epic to allow providers to access device data directly within the EHR.
The integrated workflow enables healthcare systems to easily access TytoCare-generated data in a patient’s EHR and enables clinicians to access TytoCare exam data directly within Epic’s medical records software, according to executives. of the company.
TytoCare’s collaboration with the University of Miami Health System in June 2020 helped drive the integration of Epic.
The University of Miami student-athletes and staff used TytoHome devices to capture vital signs and share test data with physicians at the University of Miami Health System. If an athlete’s vital signs were outside of normal ranges, they would be contacted for an asynchronous TytoCare exam, requiring them to log into two applications: MyChart and the TytoCare application.
The new integration allows users to log into a single application, MyChart, and use TytoCare’s “browse and share” feature, according to company executives.
RELATED: TytoCare Adds Diagnostic AI Component to Home Telehealth Kit
In 2019, TytoCare joined Epic Orchard app marketplace, which allows healthcare organizations to offer the integrated telehealth service to their care providers and patients for telehealth visits and access to patient data.
With this new integration, all patients in healthcare organizations using Epic and TytoCare will be able to log into the app and transition to the TytoCare app. TytoCare uses the API to publish the patient’s vital signs directly to the patient’s EHR.
The company is also leveraging messaging and notification capabilities to instruct clinicians to launch the TytoCare exam viewer to review audio, video, and images sent by the patient.
“We are delighted to have been able to expand our integration into MyChart, enabling healthcare organizations to drive better care through easier access and a more informed care pathway for each patient,” said Dedi Gilad, CEO and Co-Founder of TytoCare, in a statement. . “Consumers demand frictionless experiences in all aspects of their lives, and as telehealth continues to be a vital piece of the healthcare landscape, its foundational telehealth systems provide users with a seamless experience that includes remote monitoring capabilities. of patients “.
The TytoCare Manual Exam Kit allows users to perform physical examinations of the heart, skin, ears, throat, abdomen, and lungs, as well as measure blood oxygen levels, heart rate, and body temperature, which are key to the treatment of many chronic and non-acute diseases. terms.
Last year, the company implemented AI-powered features to enable its telehealth platform to perform diagnostic capabilities. The TytoCare product consists of an app and mobile device with modular accessories for various types of exams, including an ear otoscope, a heart and lung stethoscope, and a throat tongue depressor.
RELATED: TytoCare Banks an Additional $ 50 Million in Series D Funds to Expand Telehealth
In March, TytoCare secured an additional $ 50 million in serial financing in a development that doubles the company’s valuation, the company reported. That funding round was a continuation of the company’s Series D round, which began in April 2020 when it raised $ 50 million. The company has raised $ 155 million to date.
TytoCare has seen strong adoption during the pandemic and sees growth in telehealth among hospitals, insurers, and healthcare systems. The company’s revenue more than doubled in 2020. Last year, TytoCare conducted 650,000 telehealth screenings worldwide, the company said.
“The University of Miami Health System is always looking for new ways to incorporate technology that helps us deliver seamless patient care within MyChart,” said David Reis, Ph.D., System Vice President and Chief Information Officer. of Health of the University of Miami, in a statement.